{"id":"W4410805509","doi":"10.1200/edbk-25-472778","title":"Navigating B-ALL in the Era of Blinatumomab","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Dosing; Clinical trial; Intensive care medicine; Expanded access; Cytokine release syndrome; Oncology; Internal medicine; Chimeric antigen receptor; Immunotherapy; Cancer; Lymphoblastic Leukemia; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003155189,0.0002915178,0.003864054,0.00004408087,0.00004269512,0.000004405267,0.0007145755,0.0005453076,0.0002246589],"category_scores_gemma":[0.005056548,0.0001951492,0.001893872,0.0008925354,0.00299148,0.00003809793,0.0001932185,0.003481663,0.00002433688],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000914558,"about_ca_system_score_gemma":0.03824418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002608828,"about_ca_topic_score_gemma":0.000004821984,"domain_scores_codex":[0.994538,0.001111263,0.00281332,0.0005104826,0.0006761508,0.0003507776],"domain_scores_gemma":[0.954375,0.04237827,0.002065094,0.0006098239,0.0004291006,0.0001427253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003924,0.00133014,0.0003933417,0.005702587,0.0004968006,0.000004957024,0.0004727971,3.702895e-7,1.750036e-7,0.0003913742,0.055407,0.9357612],"study_design_scores_gemma":[0.001070697,0.0009724174,0.001700059,0.00996204,0.0009709665,0.00005204146,0.0007975702,0.00002387885,2.435925e-7,0.0001481676,0.9841653,0.0001366209],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00030213,0.9513645,0.00002250163,0.03971851,0.0002920839,0.001352343,0.00004348724,0.00001013563,0.006894268],"genre_scores_gemma":[0.0001473504,0.9753601,0.009298769,0.01172325,0.000619939,0.0002383997,0.0002067123,0.0000255643,0.002379915],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9356246,"threshold_uncertainty_score":0.9997218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1379274993969409,"score_gpt":0.5668002481655495,"score_spread":0.4288727487686086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}